000			nam a22 7a 4500
999			_c39291 _d39291
008			190320b2018 xxu||||| |||| 00| 0 eng d
020			_a9781107577305
082			_a610.72 REA-P
100			_aRea, Philip A.
245			_aManaging discovery in the life sciences : _bharnessing creativity to drive biomedical innovation / _cPhilip A. Rea, Mark V. Pauly and Lawton R. Burns
260			_aUnited Kingdom _bCambridge University Press _c2018
300			_a542 p.
365			_aGBP _b29.99.
500			_aIn this book, distinguished scholars Philip A. Rea, Mark V. Pauly, and Lawton R. Burns explore the science and management behind marketable biomedical innovations. They look at how the science actually played out through the interplay of personalities, the cultures within and between academic and corporate entities, and the significance of serendipity not as a mysterious phenomenon but one intrinsic to the successes and failures of the experimental approach. With newly aggregated data and case studies, they consider the fundamental economic underpinnings of investor-driven discovery management, not as an obstacle or deficiency as its critics would contend or as something beyond reproach as some of its proponents might claim, but as the only means by which scientists and managers can navigate the unknowable to discover new products and decide how to sell them so as to maximize the likelihood of establishing a sustainable pipeline for still more marketable biomedical innovations.
650			_aMedical sciences--Research
650			_aMedicine--Research
700			_aPauly, Mark V.
700			_aBurns, Lawton R.